KURA - Kura Oncology Inc logo

KURA

Kura Oncology Inc

Rev โ€”top 1%10Y
Hold

Kura Oncology develops targeted biopharmaceuticals aimed at treating cancer, with products like ziftomenib for AML and other investigational drugs for solid tumors. The company focuses on precision medicine to improve patient outcomes in oncology.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$1,926today

Score Overview

1 Year
Score
Net Growth-5.71%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth6.16%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-125.78%
Net TrendNever
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-8x
Net TrendNever
Net Income Consistency
Rev Growthโ€”
Rev Trend30%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-11x
Net TrendNever
Net Income Consistency
Rev Growthโ€”
Rev Trend27%
Revenue Consistency

See the full market ranking โ†’

Kura Oncology Inc fundamental performance

Across Kura Oncology Inc's full reported history, from 2015 to 2025, revenue grew from $ 0.00 to $ 67M and net income went from -$ 22M to -$ 278M. Revenue increased in 27% of the years measured; net income in 0%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 9.94โ€”
1 Year2025-08-12
$ 6.2060.32%
5 Years2021-08-12
$ 16.93-41.29%
10 Years2016-08-12
$ 5.1692.64%
All Time2015-09-22
$ 14.00-29.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 71M-$ 294M$ 580M
2025$ 67M-$ 278M$ 667M
2024$ 53M-$ 173M$ 727M
2023$ 0.00-$ 152M$ 423M
2022$ 0.00-$ 135M$ 437M
2021$ 0.00-$ 130M$ 517M
2020$ 0.00-$ 89M$ 633M
2019$ 0.00-$ 63M$ 236M
2018$ 0.00-$ 60M$ 178M
2017$ 0.00-$ 35M$ 93M
2016$ 0.00-$ 27M$ 67M
IPO2015$ 0.00-$ 22M$ 85M

Explore beyond KURA

You're looking at Kura Oncology Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies